Article
Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes.
Diabetes & metabolism - 1 Nov 2007
Gutierrez-Aguilar R, Benmezroua Y, Balkau B, Marre M, Helbecque N, Charpentier G, Polychronakos C, Sladek R, Froguel P, Neve B
Abstract excerpt
BACKGROUND: Transgenic mice over-expressing SMAD7 in pancreatic beta-cells develop type 2 diabetes (T2D). The expression of SMAD7 is affected by KLF11, which contains gene variants that have previously been shown to be involved in genetic susceptibility to T2D, and by the highly homologous KLF10. This study aims to assess the genetic contribution of SMAD7 and KLF10 gene variants to T2D susceptibility in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
